Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Epizyme (EPZM)
NASDAQ:EPZM
Epizyme (EPZM) Financial Statements
0 Followers
Epizyme Financial Overview
| Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 27.53M | $ 8.70M | $ 11.58M | $ 5.20M | $ 13.01M |
| Gross Profit | $ 22.33M | $ 6.10M | $ 8.43M | $ 3.20M | $ 10.52M |
| EBIT | $ -29.76M | $ -49.50M | $ -44.58M | $ -59.74M | $ -58.28M |
| EBITDA | $ -28.48M | $ -48.21M | $ -43.25M | $ -58.42M | $ -56.97M |
| Net Income Common Stockholders | $ -35.74M | $ -55.51M | $ -50.65M | $ -65.83M | $ -64.36M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 144.41M | $ 176.79M | $ 199.73M | $ 221.29M | $ 244.01M |
| Total Assets | $ 264.16M | $ 312.19M | $ 289.00M | $ 332.27M | $ 352.55M |
| Total Debt | $ 88.99M | $ 233.04M | $ 234.58M | $ 235.74M | $ 237.23M |
| Net Debt | $ -55.42M | $ 56.25M | $ 34.85M | $ 14.45M | $ -6.78M |
| Total Liabilities | $ 284.44M | $ 301.06M | $ 309.69M | $ 316.89M | $ 284.92M |
| Stockholders Equity | $ 11.12M | $ 15.38M | $ 67.63M | $ 123.03M | $ 184.90M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -54.81M | $ -59.20M | $ -52.06M | $ -42.81M | $ -56.77M |
| Operating Cash Flow | $ -54.81M | $ -59.19M | $ -51.97M | $ -42.64M | $ -56.67M |
| Investing Cash Flow | $ 48.71M | $ -44.19M | $ 18.18M | $ 66.64M | $ 60.98M |
| Financing Cash Flow | $ -257.00K | $ 82.46M | $ 7.60M | $ 20.35M | $ 2.15M |
Epizyme Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.